The Frontiers of Health Care: The Personalized Medicine Revolution

Save The Date!

Brown University - Salomon Center for Teaching

Monday June 4, 2007
8:30 am - 4:00 pm

Online Registration

Featuring a Keynote Address by:

Francis S. Collins, M.D., Ph.D.
Director, National Human Genome Research Institute
Closing Keynote Address by:

Mark McClellan, M.D., PH.D.
Former Commissioner, Food and Drug Administration (FDA) and Former Administrator of the Centers for Medicare and Medicaid Services (CMS)

Sponsored by The Warren Alpert Medical School of Brown University in conjunction with Congressman Patrick J. Kennedy.

8:00 – 8:45am	Continental Breakfast
8:45 – 9:00am	Welcome and Introductions Eli Y. Adashi, MD, MS, FACOG Dean of Medicine and Biological Sciences, The Warren Alpert Medical School of Brown University Representative Patrick J. Kennedy U.S. House of Representatives, 1st District, Rhode Island
9:00 – 9:45am	Keynote Address Francis S. Collins, MD, PhD Director, National Human Genome Research Institute
9:45 – 9:55am	Question and Answer session
9:55 – 10:05am	Break
10:05 – 11:45pm	Roundtable Hypothetical Scenario: Public Policy & Personalized Medicine Moderated by Professor Charles J. Ogletree Professor, Harvard Law School Jesse Climenko Professor of Law, and Founding and Executive Director of the Charles Hamilton Houston Institute for Race and Justice Healthcare Translation – Daniel J. Wattendorf, MD, MAJ, MC, USAF, Keesler Air Force Base Ethics – Thomas H. Murray, PhD, President & CEO, The Hastings Center Patient Advocacy – Sharon F. Terry, MA, President & CEO, Genetic Alliance Privacy – Joy L. Pritts, JD, Research Associate Professor, Health Policy Institute, Georgetown University Research – FrancisS. Collins, MD, PhD Director, National Human Genome Research Institute Institutional Review Board – P. Pearl O’Rourke, MD, Director, Human Research Affairs, ESCRO Chair, Partners Healthcare; Associate Professor, Harvard Medical School Legal – Richard A. Johnson, JD, MS, Senior Partner, Arnold & Porter LLP Economics – Edward Abrahams, PhD, Executive Director, Personalized Medicine Coalition Media – Jonathan D. Rockoff, Reporter (Washington Bureau), Baltimore Sun Insurance – James E.Purcell, JD, President, Blue Cross Blue Shield, RI Hospital – Joseph F. Amaral, MD, FACS President and CEO, Rhode Island Hospital Pharmaceutical Industry – Patrice M. Milos, PhD, Executive Director, Pfizer Politics – Paul T. Kim, AB, MPP, JD, Partner, Foley Haog LLP
11:45– 1:15pm	Lunch
1:15 – 2:45pm	Moderated discussion with the audience (Ed Hawrot, PhD, Brown University)
2:45 – 3:00pm	Break
3:00 – 3:45pm	Closing Keynote Address Mark B. McClellan, MD, PhD Former Administrator, CMS and former Commissioner, U.S. Food and Drug Administration
3:45 – 4:00 pm	Conclusion and Future Directions

Conference Description
There is great hope that personalized medicine, the use of the human genomics as applied to clinical and preventive medicine, will enable both physicians and patients to tailor their health care in the future to both prevent and treat common diseases. The completion of the Human Genome Project has greatly increased understanding of and interest in the genetic basis of disease, while also bringing a new set of complex scientific and policy matters to the forefront of genomics.

As the knowledge base grows, genomic medicine is providing the medical community an increasing ability to analyze an individual patient’s genome to determine optimal approaches to medical care, whether preventive, diagnostic, or therapeutic. However, along with this exciting progress comes significant uncharted territory regarding the application of personalized medicine, and a multitude of resulting policy issues regarding not only scientific but also economic, legal, ethical and social concerns. This meeting seeks to explore the complexities of personalized medicine from a variety of expert perspectives in order to help prepare the public, health care providers, and policy makers for the coming revolution in personalize medicine.

Conference Objectives
At the conclusion of the meeting the participants and audience will have a much greater understanding of personalized medicine and the actions that need to be taken to move it into practice, and to prepare for the changes it portends, including medical integration issues, regulatory/legal matters and issues of public policy. By clarifying the challenges faced by physicians, patients and policy makers and in exploring some of the possible solutions to the issues raised, the 2007 Frontiers conference will spur public and private efforts to accelerate and prepare for the personalize medicine revolution.

Continuing Medical Education- Physicians
The Warren Alpert Medical School of Brown University is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.